SUBSCRIBE
SUBSCRIBE
News   Business

Life Science Pharmaceuticals, Inc. Enters Into Agreement With Abbott GmbH to Develop Antibody 806

November 17, 2008 | 
1 min read
GREENWICH, Conn.--(BUSINESS WIRE)--Life Science Pharmaceuticals, Inc. announced today that it has entered into a license agreement with Abbott to develop Antibody 806, which may prove to be an important tool in the fight against cancer.
Alliances
MORE ON THIS TOPIC
Collage image of people arms gloves hold equipment hit hammer cut saw nail gun isolated on creative white background.
Executive appointments
Merck Reorganizes Human Health Work Into Two New Units
February 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS, Catalent Further Whittle Workforces
February 23, 2026
 · 
57 min read
 · 
BioSpace Editorial Staff
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
February 19, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker